HALB
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | 0.00 | $0 | — |
| 2025 Q1 | 0.00 | $0 | — |
| 2025 Q4 | 0.00 | $0 | — |
| 2025 Q3 | 0.00 | $0 | — |
| 2025 Q2 | 0.00 | $0 | — |
| 2024 Q1 | 0.00 | $0 | — |
| 2024 Q4 | 0.00 | $0 | -$530 |
| 2024 Q3 | 0.00 | $0 | — |